Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data
Journal of Racial and Ethnic Health Disparities · 2025
DOI: 10.1007/s40615-024-02047-4 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Racial and Ethnic Health Disparities, 2025. Verfasst von Moon Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, 4770 Buford Hwy NE, …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Registries, Clinical Trials as Topic. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National ALS Registry.
Abstract (Originalsprache)
Objective
To characterize the participant demographics in the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database compared with the web-portal National Amyotrophic Lateral Sclerosis (ALS) Registry (the Registry).
Methods
Demographics and ALS symptom information were compared between the self-reported registrant data in the Registry web portal (2010–2021) and the latest available PRO-ACT data (updated August 2022), which is a collection of clinical trials data.
Results
Greater percentages of younger (≤ 59 years old) but smaller percentages of older (60 + years old) participants were represented in PRO-ACT compared to Registry. Enrollment for minority race groups was greater in the Registry portal data, but race information was largely missing/unknown in PRO-ACT database. Median age at the time of diagnosis and age at the time of symptom onset were significantly higher for Registry enrollees compared to the participants of PRO-ACT. Symptom onset sites were similarly reported, but duration between self-noted symptom onset and diagnosis was slight, but significantly longer for the Registry enrollees (11 vs. 9 months). Hispanic were as likely as non-Hispanic to participate in research studies, based on the Registry data.
Conclusion
There was a notable difference in the age distribution and minority representation of enrollees between the PRO-ACT and Registry study populations. Age distribution in the PRO-ACT database skewed to a younger and less diverse cohort. Despite the clinical heterogeneity and complex disease mechanism of ALS, identifying the underrepresented demographic niche in the PRO-ACT and Registry study populations can help improve patient participation and criteria for patient selection to enhance generalizability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA, 30341, USA. ptr6@cdc.gov.
- Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA, 30341, USA.
ORCID-Profile: Moon Han, Jaime Raymond, Theodore C Larson, Paul Mehta, D Kevin Horton
Förderung
- National ALS Registry
Zitieren
APA
Han, M., Raymond, J., Larson, T. C., Mehta, P., & Horton, D. K. (2025). Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-024-02047-4
Vancouver
Han M, Raymond J, Larson TC, Mehta P, Horton DK. Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data. Journal of Racial and Ethnic Health Disparities. 2025. doi:10.1007/s40615-024-02047-4
BibTeX
@article{Han2025,
author = {Han, Moon and Raymond, Jaime and Larson, Theodore C and Mehta, Paul and Horton, D Kevin},
title = {Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data},
journal = {Journal of Racial and Ethnic Health Disparities},
year = {2025},
doi = {10.1007/s40615-024-02047-4}
}
EUVIMED